Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center – MTC located Norwood, Massachusetts, in a move that involves an investment of over $140m. By way of this onshoring, the company is now going to operate complete end-to-end mRNA medicine manufacturing throughout the country. It […]The post Onshoring of Drug Product Manufacturing to Massachusetts first appeared on World Pharma Today.
